US EditionPublished • loading... • Updated
China Accuses Pfizer of Antitrust Violations! Its Acquisition of Maxus Technologies Is Under Investigation
Summary by newtalk.tw
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Newtalk News The Chinese government announced today (15) that after preliminary investigation, Pfizer Inc. violated the Anti-Monopoly Law of the People's Republic of China and the Announcement of the Anti-Monopoly Review Decision of the State Administration for Market Regulation on Approving Pfizer Inc.'s Acquisition of the Equity Interests of Mailusi Technology Co., Ltd. with Additional Restrictive Conditions. The State Administration for Marke…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
